Correspondence to editorial on "GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma"

Affiliations

¹ Department of Gastroenterology, Ajou University School of Medicine, Suwon, Korea.
² Department of Biochemistry, Kosin University College of Medicine, Busan, Korea.

Comment

Soon Sun Kim et al. Clin Mol Hepatol. 2026 Jan.

. 2026 Jan;32(1):e72-e74.

doi: 10.3350/cmh.2025.0350. Epub 2025 Apr 4.

¹ Department of Gastroenterology, Ajou University School of Medicine, Suwon, Korea.
² Department of Biochemistry, Kosin University College of Medicine, Busan, Korea.

No abstract available

Keywords: Diagnosis; GULP PTB domain-containing engulfment adaptor 1; Hepatocellular carcinoma; Prognosis; Recurrence.

Conflict of interest statement

Conflicts of Interest

The authors have no conflicts to disclose.

GULP1: New hope for hepatocellular carcinoma: Reply to correspondence on "GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma".
Xie Y, Cao LQ, Wurpel J, Chen ZS. Xie Y, et al. Clin Mol Hepatol. 2026 Jan;32(1):e112-e114. doi: 10.3350/cmh.2025.0415. Epub 2025 Apr 28. Clin Mol Hepatol. 2026. PMID: 40294896 Free PMC article. No abstract available.

Unveiling GULP1 as a hepatocyte-specific role for recurrence: Editorial on "GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma".
Lu P, Wang N. Lu P, et al. Clin Mol Hepatol. 2026 Jan;32(1):410-412. doi: 10.3350/cmh.2025.0282. Epub 2025 Mar 19. Clin Mol Hepatol. 2026. PMID: 40107310 Free PMC article. No abstract available.

1. Xie Y, Cao LQ, Wurpel J, Chen ZS. GULP1, a multifaceted diagnostic biomarker and potential therapeutic target in hepatocellular carcinoma: Editorial on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma”. Clin Mol Hepatol. 2026;32:413–415. - PMC - PubMed
1. Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400:1345–1362. - PubMed
1. Cao LQ, Xie Y, Fleishman JS, Liu X, Chen ZS. Hepatocellular carcinoma and lipid metabolism: novel targets and therapeutic strategies. Cancer Lett. 2024;597:217061. - PubMed
1. Sha M, Wang J, Cao J, Zou ZH, Qu XY, Xi ZF, et al. Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation. Clin Mol Hepatol. 2025;31(Suppl):S285–S300. - PMC - PubMed
1. Kim HS, Yoon JH, Choi JY, Yoon MG, Baek GO, Kang M, et al. GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma. Clin Mol Hepatol. 2025;31:914–934. - PMC - PubMed